DIAGNOSIS
The diagnosis of myasthenia gravis (MG) involves a thorough evaluation of a person’s medical history, physical examination, and specific tests. Here are some key steps typically involved in the diagnosis of MG:
1. Medical history and physical examination: The healthcare professional will start by taking a detailed medical history, including information about symptoms, their progression, and any family history of neuromuscular disorders. A physical examination will be conducted to assess muscle weakness, eye movements, facial expressions, swallowing, and other relevant functions.
2. Neurological examination: A neurological examination will be performed to evaluate muscle strength, reflexes, coordination, and sensory functions. The healthcare professional will look for specific signs of myasthenia gravis, such as drooping eyelids (ptosis) and double vision (diplopia).
3. Blood tests: Blood tests are typically conducted to check for the presence of specific antibodies associated with myasthenia gravis. The most common antibodies tested for are acetylcholine receptor (AChR) antibodies and muscle-specific kinase (MuSK) antibodies. However, it is important to note that not all individuals with MG will have detectable antibodies, and in some cases, additional testing may be required.
4. Electromyography (EMG): EMG is a test that measures the electrical activity of muscles and can help assess the transmission of signals between nerves and muscles. In MG, the EMG findings may show characteristic abnormal responses, such as a decrease in muscle response with repetitive stimulation.
5. Edrophonium test: This test involves the administration of a short-acting drug called edrophonium chloride (Tensilon) to temporarily improve muscle strength in individuals with MG. The healthcare professional will monitor the response to the drug, looking for a noticeable improvement in muscle strength that lasts for a short duration.
6. Imaging studies: In some cases, imaging studies such as a chest CT scan may be performed to evaluate the thymus gland, as abnormalities in the thymus are sometimes associated with MG.
TREATMENT
The treatment of myasthenia gravis (MG) aims to manage symptoms, improve muscle strength, and enhance the quality of life for individuals living with the condition. The specific treatment approach will depend on the severity of symptoms, the muscles involved, and the individual’s overall health. Here are some common treatment options for MG:
1. Medications:
– Cholinesterase inhibitors: These medications, such as pyridostigmine (Mestinon), help improve muscle strength by increasing the levels of acetylcholine, a chemical involved in muscle contractions.
– Immunosuppressants: Drugs like prednisone, azathioprine, mycophenolate, and methotrexate are used to suppress the immune system and reduce the production of the antibodies that attack the neuromuscular junction.
– Immunomodulating therapies: In some cases, intravenous immunoglobulin (IVIG) or plasmapheresis (plasma exchange) may be used to temporarily modify the immune system and improve symptoms.
2. Thymectomy: If a thymoma (a tumor of the thymus gland) is present or if the thymus is enlarged, surgical removal of the thymus (thymectomy) may be recommended. Thymectomy can help improve symptoms and reduce the need for long-term immunosuppressive medications.
3. Supportive measures:
– Rest and pacing: Managing fatigue by allowing for sufficient rest and avoiding overexertion can be helpful in managing MG symptoms.
– Speech and swallowing therapy: If there are difficulties in speaking or swallowing, working with a speech-language pathologist can provide strategies and exercises to improve these functions.
– Assistive devices: In some cases, assistive devices such as eyepatches, prisms, or corrective lenses may be used to manage double vision.
4. Regular follow-up: Regular monitoring by a healthcare professional experienced in MG is important to assess treatment response, adjust medications as needed, and manage any potential side effects.